We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
-2.33%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$999M
AUM Growth
-$39.8M
(-3.8%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
23.26%
Holding
320
New
23
Increased
117
Reduced
113
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$11.2M |
| 2 |
Old Republic International
ORI
|
+$9.89M |
| 3 |
CME Group
CME
|
+$8.35M |
| 4 |
Vanguard Energy ETF
VDE
|
+$8.26M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$10.3M |
| 2 |
Trimble
TRMB
|
+$8.57M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$7.61M |
| 4 |
Dollar General
DG
|
+$5.39M |
| 5 |
Estee Lauder
EL
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.45% |
| 2 | Healthcare | 12.15% |
| 3 | Financials | 10.27% |
| 4 | Consumer Staples | 6.19% |
| 5 | Industrials | 6.1% |
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q1 2022 Portfolio in Review
As of Q1 2022, Dixon Hubard Feinour & Brown held 320 positions worth $999M, down 3.8% from $1.04B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Dixon Hubard Feinour & Brown's Q1 2022 filing shows 23 new, 117 increased, 113 reduced and 13 closed positions. Its largest new stake was Old Republic International: 383,256 shares worth $9.91M. The largest sale was Albemarle, an estimated $10.3M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Dixon Hubard Feinour & Brown's largest Q1 2022 buy was Old Republic International: 383,256 shares worth $9.91M.
- Dixon Hubard Feinour & Brown added most to Williams Companies in Q1 2022, an estimated $11.2M increase.
- Dixon Hubard Feinour & Brown's biggest Q1 2022 reduction was Thermo Fisher Scientific, cutting an estimated $7.61M.
- Dixon Hubard Feinour & Brown fully exited Albemarle in Q1 2022, selling an estimated $10.3M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 23% of its $999M portfolio in Q1 2022.
- Dixon Hubard Feinour & Brown opened 23 new positions and closed 13 in Q1 2022.
- Dixon Hubard Feinour & Brown's portfolio value fell 3.8% quarter-over-quarter to $999M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2022, filed 9 May 2022.